Skip to content

Morbidity of parotidectomy for benign parotid tumors with and without wound drainage: a prospective randomized multicenter study

Morbidity of parotidectomy for benign parotid tumors with and without wound drainage: a prospective randomized multicenter study - Redon study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017046
Enrollment
800
Registered
2019-04-11
Start date
2019-04-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D11.0

Interventions

Group 1: Insertion of the wound drain during parotidectomy Group 2: No insertion of the wound drain during the parotidectomy

Sponsors

HNO Uniklinik Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - benign tumor of the parotid gland - regular preoperative function of the facial nerve - No continued therapy with anticoagulants or vitamin K antagonists - primary surgery - Age > 18 years

Exclusion criteria

Exclusion criteria: - Tumors of unclear dignity or malignant tumors of the parotid gland - Preoperative facial nerve palsy - revision surgery - Inner lobe tumor of the parotid gland - Ongoing therapy with anticoagulants or Vit.K antagonists that cannot be paused for surgery - pregnancy

Design outcomes

Primary

MeasureTime frame
Number of the postoperative bleeding, which need revision surgery (during the inpatient stay)

Secondary

MeasureTime frame
Number of postoperative complications, as serum, salivary fistula, cyst, pain, jaw dysfunction after 4 weeks

Countries

Austria, Germany

Contacts

Public ContactMaria Grosheva

HNO Uniklinik Köln

maria.grosheva@uk-koeln.de02214784795

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026